MicroRNA Biomarker hsa-miR-195-5p for Detecting the Risk of Lung Cancer
Background. Lung cancer is one of the leading diagnosed cancers worldwide, and microRNAs could be used as biomarkers to diagnose lung cancer. hsa-miR-195 has been demonstrated to affect the prognosis of NSCLC (non-small-cell lung cancer) in a previous study. However, the diagnostic value of hsa-miR-...
Saved in:
Main Authors: | Lei Li, Tienan Feng, Weituo Zhang, Sumeng Gao, Ruoyang Wang, Wenwen Lv, Tengteng Zhu, Herbert Yu, Biyun Qian |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | International Journal of Genomics |
Online Access: | http://dx.doi.org/10.1155/2020/7415909 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome
by: Wenhua Tao, et al.
Published: (2016-01-01) -
MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment
by: Kouji Banno, et al.
Published: (2014-01-01) -
Circular RNA circFGFR1 Functions as an Oncogene in Glioblastoma Cells through Sponging to hsa-miR-224-5p
by: Qian Zhang, et al.
Published: (2022-01-01) -
MicroRNA as a Potential Biomarker and Treatment Strategy for Ischemia-Reperfusion Injury
by: Mingming Cao, et al.
Published: (2021-01-01) -
Plasma MicroRNA Expression Profiles in Psoriasis
by: Shiju Xiao, et al.
Published: (2020-01-01)